Scientists in Southern Africa hope to start pre-clinical trials for a new single-dose malaria drug for malaria next year.
Kelly Chibale, a Zambia-born organic chemist at South Africa’s University of Cape Town (UCT), is part of the team developing the prospective drug.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.